| Debra Marie Pierce, MD | |
|
1200 E Michigan Ave, Suite 655, Lansing, MI 48912-1800 | |
| (517) 267-2460 | |
| Not Available |
| Full Name | Debra Marie Pierce |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 1200 E Michigan Ave, Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013271436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 4301100980 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra Marie Pierce, MD 1200 E Michigan Ave, Suite 655, Lansing, MI 48912-1800 Ph: (517) 267-2460 | Debra Marie Pierce, MD 1200 E Michigan Ave, Suite 655, Lansing, MI 48912-1800 Ph: (517) 267-2460 |
News Archive
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
"Chinese authorities will step up the release of water from the Three Gorges Dam in a bid to tackle a drought in southern China which has put pressure on drinking water, crops, shipping lanes and electricity production in what is traditionally China's most water-abundant region," the Financial Times reports.
Investigators at Memorial Sloan-Kettering Cancer Center (MSKCC), along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large- scale, multi-institutional study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.
Nymox Pharmaceutical Corporation has announced that the Company's latest multi-center U.S. study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH), is nearing completion.
› Verified 6 days ago
Dr. Paul David Schneider, M.D. Surgery Medicare: Medicare Enrolled Practice Location: Sparrow Hospital - Trauma Services, 1215 E. Michigan Ave, Lansing, MI 48912 Phone: 517-267-2460 Fax: 517-267-2462 | |
Dr. Nadim El-hage, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-5902 | |
Jordyn Atwater, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave Ste 655, Lansing, MI 48912 Phone: 517-364-5902 | |
James Vincent Raccuia, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 E Michigan Ave Ste 655, Lansing, MI 48912 Phone: 517-267-2460 | |
Dr. Kurt M Carter, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 405 W Greenlawn Ave, Ste 305, Lansing, MI 48910 Phone: 517-483-4795 Fax: 517-483-4862 | |
Ms. Suzanne Marie Hanses, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 4911 W St Joe Hwy, Ste 102, Lansing, MI 48917 Phone: 517-853-3600 Fax: 517-853-0085 |